drugset / Trial / NCT03693807
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
NaSingle-groupOpen-labelTreatment
Summary
This study is being done to answer the following question: Is the combination of the Medtronic pump and the Codman catheter device a safe alternative to the C3000 Codman pump for delivering chemotherapy directly into the liver of patients with metastatic colorectal cancer or cholangiocarcinoma?
Timeline
- Start
- 2018-10-18
- Primary completion
- 2024-06-27
- Completion
- 2024-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cetuximab | Monoclonal antibody | — | — |
| Background | Floxuridine | Unknown | — | — |
| Background | Gemcitabine | Small molecule | 800 mg/m2 | Intravenous |
| Background | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Background | Irinotecan | Small molecule | — | — |
| Background | Oxaliplatin | Small molecule | 85 mg/m2 | Intravenous |
| Background | Panitumumab | Monoclonal antibody | — | — |
| Background | fluorouracil | Small molecule | — | — |